Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital.

Drew RJ, Turton JF, Hill RL, Livermore DM, Woodford N, Paulus S, Cunliffe NA.

J Hosp Infect. 2013 Aug;84(4):300-4. doi: 10.1016/j.jhin.2013.05.003. Epub 2013 Jul 5.

PMID:
23831281
2.

Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae.

Little ML, Qin X, Zerr DM, Weissman SJ.

Int J Antimicrob Agents. 2012 Jan;39(1):52-7. doi: 10.1016/j.ijantimicag.2011.09.014. Epub 2011 Nov 3.

3.
4.

Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.

Kim NH, Han WD, Song KH, Seo HK, Shin MJ, Kim TS, Park KU, Ahn S, Yoo JS, Kim ES, Kim HB.

Am J Infect Control. 2014 Dec;42(12):1270-3. doi: 10.1016/j.ajic.2014.09.004. Epub 2014 Nov 25.

PMID:
25465255
5.

Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters.

Mushtaq S, Woodford N, Hope R, Adkin R, Livermore DM.

J Antimicrob Chemother. 2013 Jul;68(7):1601-8. doi: 10.1093/jac/dkt050. Epub 2013 Feb 28.

PMID:
23449829
6.

Pediatric carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a high-prevalence region in the United States.

Pannaraj PS, Bard JD, Cerini C, Weissman SJ.

Pediatr Infect Dis J. 2015 Jan;34(1):11-6. doi: 10.1097/INF.0000000000000471.

7.
8.

Evaluation of carbapenem resistance using phenotypic and genotypic techniques in Enterobacteriaceae isolates.

Sahin K, Tekin A, Ozdas S, Akin D, Yapislar H, Dilek AR, Sonmez E.

Ann Clin Microbiol Antimicrob. 2015 Oct 6;14:44. doi: 10.1186/s12941-015-0105-1.

9.

Prevalence and Characterization of Carbapenem-Resistant Enterobacteriaceae Isolated from Mulago National Referral Hospital, Uganda.

Okoche D, Asiimwe BB, Katabazi FA, Kato L, Najjuka CF.

PLoS One. 2015 Aug 18;10(8):e0135745. doi: 10.1371/journal.pone.0135745. eCollection 2015.

10.

What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.

Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J, Woodford N.

Int J Antimicrob Agents. 2011 May;37(5):415-9. doi: 10.1016/j.ijantimicag.2011.01.012. Epub 2011 Mar 22.

PMID:
21429716
11.

Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai.

Kazi M, Drego L, Nikam C, Ajbani K, Soman R, Shetty A, Rodrigues C.

Eur J Clin Microbiol Infect Dis. 2015 Mar;34(3):467-72. doi: 10.1007/s10096-014-2249-x. Epub 2014 Sep 27.

PMID:
25260787
12.

Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.

Huang TD, Berhin C, Bogaerts P, Glupczynski Y; multicentre study group.

J Antimicrob Chemother. 2013 Aug;68(8):1832-7. doi: 10.1093/jac/dkt096. Epub 2013 Apr 3.

13.

Carbapenem non-susceptible enterobacteriaceae in Quebec, Canada: results of a laboratory surveillance program (2010-2012).

Lefebvre B, Lévesque S, Bourgault AM, Mulvey MR, Mataseje L, Boyd D, Doualla-Bell F, Tremblay C.

PLoS One. 2015 Apr 24;10(4):e0125076. doi: 10.1371/journal.pone.0125076. eCollection 2015.

14.

Emergence of carbapenem-resistant OXA-48 carbapenemase-producing Enterobacteriaceae in Tunisia.

Saïdani M, Hammami S, Kammoun A, Slim A, Boutiba-Ben Boubaker I.

J Med Microbiol. 2012 Dec;61(Pt 12):1746-9. doi: 10.1099/jmm.0.045229-0. Epub 2012 Aug 23.

PMID:
22918869
15.

Phenotypic screening of carbapenemases and associated β-lactamases in carbapenem-resistant Enterobacteriaceae.

Birgy A, Bidet P, Genel N, Doit C, Decré D, Arlet G, Bingen E.

J Clin Microbiol. 2012 Apr;50(4):1295-302. doi: 10.1128/JCM.06131-11. Epub 2012 Jan 18.

16.

Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates.

Livermore DM, Mushtaq S, Warner M, Zhang JC, Maharjan S, Doumith M, Woodford N.

J Antimicrob Chemother. 2011 Jan;66(1):48-53. doi: 10.1093/jac/dkq408. Epub 2010 Nov 14.

PMID:
21078604
17.

New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.

Deshpande P, Rodrigues C, Shetty A, Kapadia F, Hedge A, Soman R.

J Assoc Physicians India. 2010 Mar;58:147-9.

PMID:
20848811
18.

Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: a children's hospital experience.

Qin X, Zerr DM, Weissman SJ, Englund JA, Denno DM, Klein EJ, Tarr PI, Kwong J, Stapp JR, Tulloch LG, Galanakis E.

Antimicrob Agents Chemother. 2008 Nov;52(11):3909-14. doi: 10.1128/AAC.00622-08. Epub 2008 Sep 2. Erratum in: Antimicrob Agents Chemother. 2009 Jan;53(1):340.

19.

Dissemination and spread of New Delhi Metallo-beta-lactamase-1 Superbugs in hospital settings.

Khan E, Irfan S, Sultan BA, Nasir A, Hasan R.

J Pak Med Assoc. 2016 Aug;66(8):999-1004.

20.

[Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].

Eser OK, Altun Uludağ H, Ergin A, Boral B, Sener B, Hasçelik G.

Mikrobiyol Bul. 2014 Jan;48(1):59-69. Turkish.

Supplemental Content

Support Center